These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 36217821)

  • 1. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome.
    Navarro-Romero A; Galera-López L; Ortiz-Romero P; Llorente-Ovejero A; de Los Reyes-Ramírez L; Bengoetxea de Tena I; Garcia-Elias A; Mas-Stachurska A; Reixachs-Solé M; Pastor A; de la Torre R; Maldonado R; Benito B; Eyras E; Rodríguez-Puertas R; Campuzano V; Ozaita A
    Elife; 2022 Oct; 11():. PubMed ID: 36217821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
    Lysenko LV; Kim J; Henry C; Tyrtyshnaia A; Kohnz RA; Madamba F; Simon GM; Kleschevnikova NE; Nomura DK; Ezekowitz RA; Kleschevnikov AM
    PLoS One; 2014; 9(12):e114521. PubMed ID: 25474204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
    Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional Mitochondria in the Cardiac Fibers of a Williams-Beuren Syndrome Mouse Model.
    Abdalla N; Tobías-Baraja E; Gonzalez A; Garrabou G; Egea G; Campuzano V
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.
    Nass SR; Steele FF; Ware TB; Libby AH; Hsu KL; Kinsey SG
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):233-241. PubMed ID: 34042520
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
    Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder.
    Zou M; Liu Y; Xie S; Wang L; Li D; Li L; Wang F; Zhang Y; Xia W; Sun C; Wu L
    Open Biol; 2021 Feb; 11(2):200306. PubMed ID: 33529552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
    Paredes-Ruiz KJ; Chavira-Ramos K; Galvan-Arzate S; Rangel-López E; Karasu Ç; Túnez I; Skalny AV; Ke T; Aschner M; Orozco-Morales M; Colín-González AL; Santamaría A
    Neurotox Res; 2023 Dec; 41(6):514-525. PubMed ID: 37458923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
    Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP
    Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
    Sciolino NR; Zhou W; Hohmann AG
    Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
    Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
    von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
    Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
    Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
    Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.
    Zhang X; Thayer SA
    Neuropharmacology; 2018 Jan; 128():269-281. PubMed ID: 29061509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autistic disorder in patients with Williams-Beuren syndrome: a reconsideration of the Williams-Beuren syndrome phenotype.
    Tordjman S; Anderson GM; Botbol M; Toutain A; Sarda P; Carlier M; Saugier-Veber P; Baumann C; Cohen D; Lagneaux C; Tabet AC; Verloes A
    PLoS One; 2012; 7(3):e30778. PubMed ID: 22412832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model.
    Fernández-Suárez D; Celorrio M; Riezu-Boj JI; Ugarte A; Pacheco R; González H; Oyarzabal J; Hillard CJ; Franco R; Aymerich MS
    Neurobiol Aging; 2014 Nov; 35(11):2603-2616. PubMed ID: 24973119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
    Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
    Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.
    Crowe MS; Leishman E; Banks ML; Gujjar R; Mahadevan A; Bradshaw HB; Kinsey SG
    Br J Pharmacol; 2015 Apr; 172(7):1700-12. PubMed ID: 25393148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.